The zebrafish enteric nervous system (ENS), like those of all other vertebrate species, is principally derived from the vagal neural crest. The developmental controls that govern the specification and patterning of the ENS are not well understood. To identify genes required for the formation of the vertebrate ENS, we preformed a genetic screen in zebrafish. We isolated the lessen (lsn) mutation that has a significant reduction in the number of ENS neurons as well as defects in other cranial neural crest derived structures. We show that the lsn gene encodes a zebrafish orthologue of Trap100, one of the subunits of the TRAP/mediator transcriptional regulation complex. A point mutation in trap100 causes a premature stop codon that truncates the protein, causing a loss of function. Antisense-mediated knockdown of trap100 causes an identical phenotype to lsn. During development trap100 is expressed in a dynamic tissue-specific expression pattern consistent with its function in ENS and jaw cartilage development. Analysis of neural crest markers revealed that the initial specification and migration of the neural crest is unaffected in lsn mutants. Phosphohistone H3 immunocytochemistry revealed that there is a significant reduction in proliferation of ENS precursors in lsn mutants. Using cell transplantation studies, we demonstrate that lsn/trap100 acts cell autonomously in the pharyngeal mesendoderm and influences the development of neural crest derived cartilages secondarily. Furthermore, we show that endoderm is essential for ENS development. These studies demonstrate that lsn/trap100 is not required for initial steps of cranial neural crest development and migration, but is essential for later proliferation of ENS precursors in the intestine.
INTRODUCTION
The enteric nervous system (ENS) is derived from multipotent precursor cells that migrate from the neural crest to the intestine (Furness, 1987; . In all vertebrate species studied, the majority of the ENS is derived from neural crest cells that migrate from the vagal region (Newgreen and Young, 2002b) . As the ENS precursors migrate, they proliferate and differentiate to form a wide variety of neuronal subtypes (Furness, 1987; . Molecules in the environment as well as lineage restrictions within the ENS precursors determine the number and specific cell fates acquired by these precursors. Failure of ENS precursors to colonize the complete gut results in the absence of enteric ganglia along varying lengths of the colon (colonic aganglionosis) (Newgreen and Young, 2002a; Newgreen and Young, 2002b) . This is the most common cause of congenital intestinal obstruction in humans and is clinically referred to as Hirschsprung's disease (HSCR) (Kapur, 1999b; Newgreen and Young, 2002a) .
The molecular mechanisms that control the specification differentiation and proliferation of the neural crest have been studied extensively. Several secreted signalling molecules and their associated receptors have been identified that control directly and indirectly the morphogenesis of the ENS. These include GDNF (Cacalano et al., 1998; Enomoto et al., 1998; Moore et al., 1996; Pichel et al., 1996; Schuchardt et al., 1994) , neurturin (Heuckeroth et al., 1999; Heuckeroth et al., 1998; Rossi et al., 1999) , endothelin 3 Hosoda et al., 1994; Yanagisawa et al., 1998) , BMP2/4 (Chalazonitis et al., 2004; Wu and Howard, 2002) , Ihh (Indian hedgehog) (Ramalho-Santos et al., 2000) , Shh (sonic hedgehog) (Fu et al., 2004; Ramalho-Santos et al., 2000; Sukegawa et al., 2000) , NT3 (Chalazonitis et al., 2001; Chalazonitis et al., 1994) and CNTF (Chalazonitis et al., 1998) .
In addition to these signalling molecules, a number of transcription factors have been implicated as having a role in the specification of the ENS including Mash1 (Guillemot et al., 1993) , Phox2b (Pattyn et al., 1999) , SOX10 (Herbarth et al., 1998; Kapur, 1999a; Pattyn et al., 1999; Southard Smith et al., 1998) , Hox11l1 (Hatano et al., 1997; Shirasawa et al., 1997) , Hoxb5 (Kuratani and Wall, 1992; Pitera et al., 1999) , Hand2 Howard et al., 1999; Srivastava et al., 1995; Wu and Howard, 2002) and AP2␣ (BarralloGimeno et al., 2004; Knight et al., 2003; O'Brien et al., 2004) . Perturbation of the function of these signalling molecules and transcription factors leads to defects in ENS. Furthermore, mutations in some of these genes have been identified in patients affected with HSCR (Amiel and Lyonnet, 2001; Puri et al., 1998) ; however, mutations in these known genes can only account for ~60% of familial HSCR (Amiel and Lyonnet, 2001; Puri et al., 1998) .
Classical genetic studies of development have proven their utility in creating a molecular underpinning of the metazoan body plan, but the model organisms exploited to create that framework lack many of the organs found in vertebrates. To date, the genes identified as involved in ENS development have been identified indirectly. We therefore conducted a forward genetic screen in zebrafish to identify genes that when mutated would cause perturbations in the development of the ENS. One of the mutants we identified in this screen is lessen (lsn). Fish with a mutation in lsn have a significant reduction in the number of enteric neurons but also have defects in other neural crest and non-neural crest derived tissues, including the CNS and the intestine. We show that the lsn mutation disrupts a lessen encodes a zebrafish trap100 required for enteric nervous system development zebrafish trap100 (thrap4 -Zebrafish Information Network) that is required for the proliferation of enteric precursors within the embryonic intestine. Furthermore, we also show that trap100 is specifically required for the normal development of other cranial neural crest-derived structures, revealing that this gene has previously unappreciated tissue specific functions during embryogenesis. Transplantation of wild-type endoderm into lsn/trap100 mutants induces posterior pharyngeal arch cartilage development, which indicates that trap100 acts autonomously in the endoderm. Consequently this suggests that neural crest defects are secondary to endoderm defects in lsn/trap100 mutants. This is consistent with our finding that the ENS fails to develop in zebrafish that lack intestinal endoderm.
MATERIALS AND METHODS

Zebrafish maintenance and breeding
Fish were raised and kept under standard laboratory conditions at 28.5°C (Westerfield, 1993) . Embryos were staged and fixed at specific hours or days post fertilization (hpf or dpf), as described by Kimmel et al. (Kimmel et al., 1995) . To better visualize internal structures in some experiments, embryos were incubated with 0.2 mM 1-phenyl-2-thiourea (Sigma) to inhibited pigment formation (Westerfield, 1993) .
Immunocytochemistry
Embryos were processed for immunocytochemistry as previously described (Raible and Kruse, 2000) . Differentiated enteric neurons and cranial ganglia neurons were revealed with the anti-Hu mAb 16A11 (Molecular Probes) that labels differentiated neurons (Marusich et al., 1994) . Serotonergic neurons were identified with an anti-5HT rabbit polyclonal antisera (Immunostar). ENS precursors were revealed with an anti-Phox-2b rabbit polyclonal antisera (Pattyn et al., 1997) . Proliferating cells were identified using an anti phosphohistone-H3 mAb clone (Ser10) (Upstate) (Ajiro et al., 1996) . All mAbs were visualized using an Alexa Fluor 568 anti-mouse IgG antibody (Molecular Probes) or an Alexa Fluor 488 anti-mouse IgG antibody in double-label experiments (Molecular Probes). The rabbit polyclonal Ab was visualized using an Alexa Fluor 568 anti-rabbit IgG antibody (Molecular Probes).
Mutagenesis and screening
Males of the AB line treated with ENU as described previously bred with wild-type females for at least two generations, then in-crossed to derive recessive mutations to homozygosity (Haffter et al., 1996) . Clutches of incrossed 96 hpf embryos were fixed and processed for immunocytochemistry using anti Hu mAb 16A11. The number of enteric neurons was determined in a 10-somite segment of the intestine extending anteriorly from the end of the yolk extension as described previously (Shepherd et al., 2004) .
Apoptosis assay
Apoptotic cell death was detected in whole embryos by terminal transferase dUTP nick-end labelling (TUNEL) (In situ Cell Death Detection Kit; POD; Roche) as described (Knight et al., 2003) .
Cartilage staining and histological methods
Cartilages were stained with Alcian Blue as described (Schilling et al., 1996) . Embryos that were sectioned for histology were fixed and embedded in JB-4 and plastic sections were preformed as described previously (Pack et al., 1996) .
Whole-mount in situ hybridization
Embryos were collected and processed for whole-mount in situ hybridization as previously described (Thisse et al., 1993) . Digoxigeninlabelled and fluorescein-labelled riboprobes were synthesized from templates linearized with BamHI using T7 RNA polymerase for trap100. Other digoxigenin-labelled riboprobes used in this study were synthesized from templates linearized and transcribed as follows: crestin (Rubinstein et al., 2000) , SacI and T7; phox2b (Shepherd et al., 2004) , NotI and T7; dlx2a (Akimenko et al., 1994) and foxn1 (Schorpp et al., 2002) , BamHI and T7; rag1 (Willett et al., 1997) , HindII and T7; epha4 (Xu et al., 1995) , EcoRI and T3; hoxb4 (Prince et al., 1998) , KpnI and T3; ifbp (Andre et al., 2000) , trypsin (Mayer and Fishman, 2003) , pax9 (Nornes et al., 1996) and gata6 (Pack et al., 1996) , SalI and T7; foxa2 (Strahle et al., 1993) , SacI and T3; ptc1 (Concordet et al., 1996) , BamHI and T3; shh (Ekker et al., 1995) , HindII and T7; ret (Bisgrove et al., 1997) , NotI and T7; and gfra1a (Shepherd et al., 2001 ) and nos1 (previously nnos) (Poon et al., 2003) , NotI and Sp6. Digoxigenin-labelled probes were visualized with NBT/BCIP coloration reactions, while fluorescein-labelled riboprobe was visualized with Fast Red (Roche). Cross-sections of whole-mount in situ hybridized embryos were cut using a Reichardt Jung cryostat. Embryos were equilibrated in 20% sucrose in PBS solution and frozen in OCT. Sections (30 m) were collected on Fisher super frost slides rehydrated in PBS and mounted in gel mount (Fisher).
Mapping and molecular analysis of lsn
The lsn w24 (AB background) mutation was mapped by out-crossing into the polymorphic wild-type strain WIK, followed by in-breeding of heterozygous progeny. We scanned the genome for linked SSLP markers by bulked segregant analysis using standard methods (Shimoda et al., 1999; Stickney et al., 2002; Talbot and Schier, 1999) . This analysis placed the lsn mutation on linkage group 12 between z9891 and z4373, an interval of ~10 cM. Fine mapping using other SSLP markers and SNPs in 3ЈUTRs and intronic regions of ESTs that map to this region were used to further narrow the genetic interval. Using this approach, we identified one EST Fa05b04 for which we had 0 recombinants out of 1122 meiosis screened. This EST encodes a zebrafish trap100. We analyzed this candidate gene by complete sequencing of its cDNA isolated by RT-PCR from wild type and mutant embryos. The trap100 cDNA isolated from mutants was found to have a base substitution at codon 189 of the 2970 codon open reading frame. This result was substantiated by sequencing PCR products from genomic DNA derived from 12 mutants, 12 phenotypically wild-type siblings as well as 12 unrelated wild types. The GenBank Accession Number for zebrafish trap100 is DQ300265.
Embryonic microinjections
trap100 mRNA was synthesized using the mMessage mMachine kit (Ambion) and injected at a concentration of 50 ng/l. The mRNAs were coinjected with GFP mRNA, also at a concentration of 50 ng/l, to assess expression. Approximately 1 nl of diluted mRNA was injected into one-to two-cell embryos using a gas-driven microinjection apparatus (Model# MMPI-2; Applied Scientific Instrumentation) through a micropipette.
Morpholino antisense oligonucleotides (Gene Tools) were designed corresponding to the start site and the with splice junction at the end of exon 3 of the genomic trap100 sequence. The sequences were as follows: +1/+25, CCTGTTTCAGATTCACCACCTTCAT; +199/int 3, GTGTGTTTACCT-GTGAACTGATGGC.
The oligos were resuspended in sterile filtered water and diluted to working concentrations at 1-5 g/l. Approximately 1 nl of diluted morpholino was injected into one-to two-cell embryos using a gas-driven microinjection apparatus. Efficacy of the morpholino directed against the splice junction of exon 3 was evaluated using RT-PCR with a forward primer corresponding to the 131 bp of trap100 (AGCTCTTCTGGAGCAGGCTA) in conjunction with a reverse primer designed to 471 bp of trap100 (GGCCCTCAGACTGCTTTCTA). casanova morpholino was designed to the previously described morpholino translation blocking sequence (Dickmeis et al., 2001) .
Transplantation experiments
Donor and host embryos were generated from an in cross of lsn heterozygotes. Donor embryos at the one-to two-cell stage were injected with 1.5 pg of Tar* mRNA combined with a mixture of 5% Biotin-dextran (10 K lysine fixable; Molecular Probes) and 5% fluorescein-dextran (10 K Lysine fixable; Molecular Probes) to convert most of the donor cells to an endodermal cell fate (Peyrieras et al., 1998) . Tar* mRNA were synthesized using the mMessage mMachine kit (Ambion) as described above. At the sphere stage, 20-40 donor cells were transplanted into unlabelled sibling host embryos. Embryos were then cultured in embryo medium with 10 U/ml penicillin and 10 U/ml streptomycin. Host embryo jaw cartilage development was determined on day 5 by Alcian Blue straining as described above. Donor cells from the transplant were detected in hosts using an avidin-biotinylated complex (ABC kit, Vectastain) and a DAB substrate. Genotypes of the host and donor embryos were determined by sequencing.
RESULTS
lsn mutant isolation
In zebrafish, differentiated enteric neurons can be first detected at the anterior end of the intestine immunocytochemically at 72 hpf (Bisgrove et al., 1997; Kelsh and Eisen, 2000; Shepherd et al., 2001; Shepherd et al., 2004) . By 96 hpf, enteric neurons can be identified along the complete length of the intestine. We screened ENUmutagenized zebrafish for recessive mutations that interfere with the neurogenesis in the ENS. Clutches of embryos were obtained from pair-wise crosses of in-crossed F2 families. The clutches of embryos were immunocytochemically stained with an anti-Hu antibody (Marusich et al., 1994 ) to reveal differentiated neurons and then screened under a fluorescent microscope. We identified a mutant allele (lsn w24 ) in which there was a significant reduction in the number of enteric neurons at 96 hpf (Fig. 1) . lsn embryos have a 66% reduction in the number of enteric neurons over a 10-somite length segment stretching anteriorly from the cloaca (Fig. 3D ). This reduction in enteric neurons in lsn mutants is more pronounced in the more distal part of the intestine when compared with the anterior part. Further analysis of subtypes of ENS neurons in lsn mutants, specifically serotonergic neurons by immunocytochemistry and nNOS-positive neurons by in situ hybridization, shows that there is a similar reduction in the number of these specific subtypes when compared with wild type at 96 hpf (see Fig. S1 in the supplementary material). These data suggest that different enteric neuron subtypes are equally affected in lsn mutants. Neuronal differentiation in other areas of the PNS appears normal in lsn mutants. The dorsal root ganglia, sympathetic neurons and cranial ganglia are present and are comparatively normal at 96 hpf, based on anti-Hu immunocytochemistry ( Fig. 3 ; see Fig. S2 in the supplementary material). Further analysis of cranial ganglia development by in situ hybridization using a phox2b probe (Elworthy et al., 2005) also shows that the ganglia are normally specified at 48 hpf (see Fig. S2 in the supplementary material). The mutation is recessive lethal and 100% penetrant in all backgrounds tested (AB and WIK). Mutant embryos die by 7 dpf. We called the mutant lessen (lsn) as the mutants had less enteric neurons than wild type.
lsn mutants also have other defects in structures that are derived completely or receive cellular contributions from the neural crest. The most severely affected structures appear to be predominantly those that are derived from or receive contributions from the vagal/post-otic neural crest cells (Lam et al., 2002; Schilling and Kimmel, 1994) . At 5 dpf lsn mutants fail to develop the most posterior ceratobranchial cartilages (cb 4,5), while the more anterior ceratobranchial cartilages and the other anterior cartilages of the jaw are lese severely affected ( Fig. 2A-D ). In addition, there is cardiac oedema apparent from 96 hpf and the thymus primordium appears not to form normally, based on reduced Rag1 in situ expression (Fig. 2E, F) (Willett et al., 1997) . Whether the cardiac or thymus defects are due to neural crest defects has not been determined.
Other neural crest derived tissues appear unaffected in lsn mutants. We detected no difference in the normal pattern of melanophores or iridophores by light microscopy at 96 hpf (Fig. 1) . In situ hybridization studies using in situ probes for sox10 (Dutton et al., 2001 ) and nacre (Lister et al., 1999) at 24 hpf revealed no detectable difference in the pattern of expression of these two markers, suggesting that neural crest derived pigment cell development is unaffected in lsn (data not shown). We also examined the pattern of sox10 at 48 hpf as a marker of glial cells along the posterior lateral line (Kelsh and Eisen, 2000) and detected no difference in the pattern of staining in lsn when compared with wild type (data not shown). Together this suggest that the lsn mutation does not affect all neural crest-derived tissues but instead affects specific axial subpopulations of neural crest cells.
The lsn w24 mutation disrupts a zebrafish trap100 We identified the affected gene disrupted in lsn by mapping and molecular analysis of the lsn w24 mutation. Genetic mapping localized lsn to linkage group 12 (LG.12) between markers z9891 and z4373 (Fig. 3A) . By scoring 1122 meioses, we established a fine map of the region using both microsatellite markers and SNPs in the 3ЈUTR or intronic regions of known genes or ESTs that had been mapped to this the crucial interval. Using this approach, we identified a zebrafish EST (fa05b04) that had no recombinants out of the 1122 meioses. Sequence analysis suggested that fa05b04 encoded a zebrafish homologue of Trap100, a component of the Trap/mediator transcriptional regulation complex (Malik and Roeder, 2000; Myers and Kornberg, 2000; Rachez and Freedman, 2001 ). We cloned and sequenced this gene and verified by sequence comparison of the complete ORF that we had identified a zebrafish trap100 orthologue of mouse and human Trap100/TRAP100 (Thrap4/THRAP4; Mouse Genome Informatics and Human Gene Nomenclature Database) ( Fig. 3B) (Yuan et al., 1998; Zhang and Fondell, 1999) .
To determine if there was a mutation in this trap100 orthologue in lsn, we used RT-PCR to amplify the complete ORF of the zebrafish trap100 gene from genotypically homozygous wild-type and homozygous mutant 48 hpf embryos. Sequencing of these RT-PCR products revealed that the lsn mutant trap100 has a T to A base 397 RESEARCH ARTICLE A zebrafish trap100 mutant substitution that results in a premature stop codon at amino acid 63 in the N-terminal part of protein (Fig. 3C ). This base is located in the third exon of the trap100 gene. Sequencing of this exon from genomic DNA isolated from morphologically identified 96 hpf lsn mutant embryos showed that all homozygous mutant embryos have this base substitution, while all homozygous wild-type siblings lack this base change. As the predicted Trap100 protein made in lsn mutants will be severely truncated (63 amino acids long as opposed to 989) and all the predicted functional domains will be missing in this truncated protein, we believe that lsn is a null allele of trap100.
As a further demonstration that trap100 is responsible for the lsn phenotype, we performed rescue experiments using mRNA and cDNA that encoded wild-type trap100. To score the effectiveness of the rescue, we counted the number of enteric neurons in a 10-somite segment of the intestine stretching anteriorly from the anus. Microinjection of either trap100 mRNA or cDNA into embryos at the one-to two-cell stage partially rescued the number of enteric neurons in homozygous mutant embryos when compared with control injected embryos ( Fig. 3D ; data not shown). No overexpression phenotype was observed when mRNA or cDNA was injected into heterozygous and homozygous wild-type siblings ( Fig.  3D and data not shown).
To provide additional evidence that reduction in trap100 function causes the lsn phenotype, we injected one-to two-cell stage embryos with a morpholino antisense oligonucleotide directed against the putative translation start site of the gene or with a splice-blocking morpholino directed against the splice donor site at the end of exon 3. Injection of either morpholino resulted in jaw morphology, cardiac oedema and the enteric phenotypes similar to those displayed by lsn mutants (Fig. 4) . The morphant phenotypes were the same for both morpholinos. In the case of the splice-blocking morpholino, the morphant phenotype correlated with a dramatic change in trap100 transcripts in which adjoining introns are not spliced correctly as detected by RT-PCR using primers that amplify over these splice sites (data not shown). Notably, morpholino injections did not increase the severity of phenotype when injected into homozygous lsn w24 mutants, supporting the notion that lsn w24 is a complete loss-of-function mutation. trap100 expression Zebrafish trap100 is maternally expressed as determined by RT-PCR and in situ hybridization. Through the 10-somite stage, expression is ubiquitous (Fig. 5A-C) . Subsequently trap100 expression starts to become more restricted with expression becoming reduced in the trunk and tail tissue while remaining high in more anterior parts of the embryo. By 24 hpf trap100 is no longer detected in the trunk and tail (Fig. 5D,E) . Widespread expression is maintained in anterior parts of the embryo in both neural and nonneural tissue extending the length of the hindbrain including through out the pharyngeal arches. Expression is also present in the anterior parts of the gut tube. The pattern of expression at 48 hpf is essentially the same as that seen at 24 hpf but expression now extends along nearly the complete length of the gut (Fig. 5F ). Cross-sections taken at the level of somite 4 show that the expression in the gut is throughout the mesendoderm (Fig. 5G) . Although expression remains widespread throughout the neural and non-neural tissue in anterior parts of the embryo, three areas of higher expression of trap100 can be seen in the CNS: in the dorsal forebrain, in the ventral midbrain and in a stripe of expressing cells in the dorsal posterior part of the midbrain (Fig. 5F ). At 60 hpf, cross-sections through the anterior part of the gut show that trap100 expression is restricted to intestinal epithelial cells (Fig. 5H,I ). Double-label in situ hybridization studies using a trap100 probe in conjunction with a phox2b probe show that trap100 is not expressed in the ENS precursors (Fig. 5H,I ). By 72 hpf expression of trap100 becomes much more restricted (Fig. 5J,K) . Expression in the CNS is restricted to discrete groups of cells in the diencephalon, in the ventral midbrain and in a stripe of cells in the dorsal posterior part of the midbrain. Weak expression can also be detected in the retina predominantly restricted to the margin. Outside of the CNS expression becomes restricted to the pharyngeal endoderm. This expression extends into the most anterior part of the gut endoderm but does not extend to more posterior parts of the gut. Pharyngeal endoderm expression is maintained through 96 hpf, the latest age we examined in the present study (data not shown). trap100 is not required for endoderm-intestinal transition To determine whether the enteric defect was also associated with other defects in intestinal development we examined cross-sections of mutant embryos (Fig. 6A,B) . At 96 hpf, the gut tubes of the mutant embryos appear smaller and less well organized when compared with wild-type and heterozygous siblings. Similarly, the liver and pancreas are present in the mutant embryos but they are reduced in size when compared with their wild-type siblings. We examined the expression pattern of several early markers of intestinal development by in situ hybridization, including foxa2 (Odenthal and Nusslein-Volhard,
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Development 133 (3) 1998; Strahle et al., 1993) , gata6 (Pack et al., 1996) , shh (Ekker et al., 1995; Roy et al., 2001 ) and ptc1 (Concordet et al., 1996; Lewis et al., 1999) in genotyped wild-type and lsn homozygous mutant embryos.
No difference was detected in the expression pattern of these genes (data not shown). To determine if the reduction in size of the gut tube and the pancreas seen at 96 hpf was associated with a failure of these organs to functionally differentiate, we carried out an in situ analysis using probes to trypsin and intestinal fatty acid binding protein (ifbp) (Fig. 6C-F) (Andre et al., 2000; Mayer and Fishman, 2003) . Both genes were expressed in lsn/trap100 mutants in comparatively normal expression patterns, suggesting that the gut tube and the pancreas have undergone cytodifferentiation into more mature organs, unlike the recently identified npo mutant (Mayer and Fishman, 2003) . Although differentiation has occurred normally, the normal looping of the gut has failed to occur, leading to an apparent straight gut tube (Fig. 6F) . Together, these results suggest that, although gut and intestinal organ development is less advanced in the lsn mutants, there has been no arrest in intestinal development and that lsn/trap100 is not essential for the differentiation of intestinal endoderm derivatives.
trap100 is not required for neural crest specification or initial migration and patterning To determine the point at which neural crest development is disrupted in lsn, we analyzed the expression of molecular markers of the premigratory and migrating neural crest. By gross morphology, lsn mutants appear normal until about 84 hpf. There is no difference in the specification or the initial migration of the cranial neural crest in lsn mutants when compared with wild-type siblings as determined by in situ using the pan-crest specific marker crestin (Luo et al., 2001; Rubinstein et al., 2000) or by using other neural crest markers Sox10 and Foxd3 (see Fig. S3 in the supplementary material; data not shown). Furthermore, no 399 RESEARCH ARTICLE A zebrafish trap100 mutant Fig. 3. Positional cloning of lsn. (A) lsn w24 maps on to linkage group 12 between markers z9891 and z4373. No recombinants were found between lsn w24 and a SSCP marker in the 3Ј UTR of an EST (Fa05b04) that encodes for a zebrafish trap100. We isolated a fulllength cDNA corresponding to trap100 from homozygous-lsn mutant and wildtype embryos and 12 independent clones were completely sequenced in both directions. A T to A (encoding Y to stop) mutation was identified in trap100 cDNAs derived from homozygous-lsn mutants. (B) A schematic illustrating the overall structure and percentage similarity between human, mouse and zebrafish Trap100, and the predicted truncated Trap100 in lsn mutants. (A) is not due the effect of the trap100 morpholino. Embryos injected with the trap100 morpholino were obtained from an incross of nacre homozygous fish (Lister et al., 1999) and lack melanophores because of a mutation in mitfa.
difference is detected in the patterning of the hindbrain from which the cranial crest neural crest arises as detected by in situ hybridization using epha4 and hoxb4 (Prince et al., 1998; Schilling and Kimmel, 1994; Xu et al., 1995 ) (see Fig. S3 in the supplementary material).
We subsequently analyzed the migration and initial patterning of the jaw cartilages and the patterning of the thymus in genotyped embryos to determine if these structures had early defects in crest precursor migration or specification. No difference is observed in the migration of neural crest precursors to the jaw using a dlx2a (Akimenko et al., 1994) in situ probe or in their initial differentiation as determined by the expression of pax9 (Nornes et al., 1996 ) (see Fig. S4 in the supplementary material). Furthermore, no difference is observed in the initial patterning and specification of the thymus at 48 hpf, as determined using an in situ probe for the early thymus marker Foxn1 (Schorpp et al., 2002 ) (see Fig. S4 in the supplementary material).
We next examined the initial migration of the enteric precursors to the gut tube from the vagal region by in situ hybridization using the pan-crest specific marker crestin (Luo et al., 2001; Rubinstein et al., 2000) (Fig. 7A,B) or using more specific enteric precursor markers gfra1a and ret (data not shown) (Bisgrove et al., 1997; Shepherd et al., 2004) . No difference in the expression of these markers is detected prior to 48 hpf. However, at 48 hpf a difference in ENS development can be detected. In wild-type embryos, ENS precursors can be seen along the entire length of the intestine at 48 hpf (Fig. 7C) (Shepherd et al., 2004) . By contrast, in lsn homozygous mutants enteric precursors have only migrated to the anterior part of the intestine by 48 hpf (Fig. 7D) . The lack of enteric precursor cells in the more posterior parts of the intestine is maintained at 60 and 72 hpf, as determined both by in situ using probes for phox2b (Elworthy et al., 2005; Shepherd et al., 2004) , gfra1a (Shepherd et al., 2001) , ret (Bisgrove et al., 1997) and nos1 (Poon et al., 2003) , and by immunocytochemistry using an anti-phox2b antibody (Pattyn et al., 1997) (Fig. 7E-H; Fig. 8A,C) . These results are consistent with the Hu immunocytochemistry that was used to identify the lsn mutants (Fig. 1D,F) .
Development 133 (3) 
Proliferation of migrating ENS precursors in the intestine is reduced in lsn mutants
Our results imply that the initial formation and specification of ENS precursors from the premigratory vagal neural crest as well as the initial migration of ENS precursors to the anterior end of the intestine is normal in lsn embryos. Similarly, these data suggest that the initial specification and patterning of the other neural crestderived structures is not overtly perturbed in the lsn mutant. To determine why the ENS precursors subsequently fail to populate the entire length of the intestine, we examined whether this phenotype resulted from an absence or reduction in gdnf expression along the intestinal mesendoderm. Previously, we have shown GDNF is crucially required for ENS precursor migration along the intestine (Shepherd et al., 2001) . gdnf expression is unchanged in lsn mutants when compared with wild type (see Fig. S5 in the supplementary material) . This result combined with the observation that lsn ENS precursors have a normal expression of GDNF receptor components suggests the lsn ENS phenotype does not result from a perturbation of this signalling pathway.
To determine whether the lsn ENS phenotype resulted from an increase in cell death of ENS precursors, we examined whether there was an increase in the number of cells undergoing apoptosis in the intestine of 48 and 72 hpf lsn embryos when compared with wild-type siblings using TUNEL assay (Gavrieli et al., 1992) . At both ages, we observed very few cells undergoing apoptosis in the intestines of either wild-type or lsn mutant embryos, consistent with the recent study by Ng et al. (Ng et al., 2005 ) (see Fig. S5 in 401 RESEARCH ARTICLE A zebrafish trap100 mutant the supplementary material). We determined that there is no difference between the number of cells undergoing apoptosis in the intestine of mutant embryos and wild-type siblings at either age. Given the absence of an increase in the number of cells undergoing apoptosis in the intestine of lsn mutants, we examined whether the phenotype resulted from a decrease or lack of in proliferation of ENS precursors once they reached the intestine. As previously noted, lsn mutants have a significant reduction in the number of ENS precursors in the intestine at 48 hpf as detected by Phox2b immunocytochemistry (Fig. 8) and by other ENS precursors specific markers using in situ hybridization (Fig. 7 and data not  shown) . By undertaking double label immunocytochemistry with the Phox2b antibody and an antibody for phosphohistone H3, a marker of proliferating cells (Ajiro et al., 1996) , we determined that there is a 88% reduction in the number of proliferating ENS precursors at 48 hpf (Fig. 8E) . This result suggests that the decrease in the number of ENS precursors seen at 96 hpf is caused at least in part the by the reduction in ENS precursor proliferation. lsn/trap100 is required non-cell autonomously for pharyngeal arch neural crest cells As lsn/trap100 mutants exhibit defects in the neural crest derived head skeleton and trap100 is widely expressed through out the pharyngeal arch mesendoderm we tested whether lsn/trap100 is required only in the mesendoderm. We attempted to rescue lsn/trap100 mutant cartilages by placing wild-type cells into the pharyngeal mesendoderm. Transplantation of unmanipulated wildtype cells usually results in small mesendedormal clones. To achieve larger clones in endodermal pouches, we injected wild-type donors prior to transplantation with Tar*, an activated version of the type1 TGF␤-related receptor Taram A (Tar) to convert blastomeres to an endodermal fate (David and Rosa, 2001; David et al., 2002; Peyrieras et al., 1998) (Fig. 9A) . As expected, donor cells in the mosaic embryos contribute largely to the pharynx, endodermal pouches of the pharyngeal arches and only very rarely to the entire length of the digestive tract. In seven out of nine lsn larvae (78%) in which transplanted wild-type cells contributed to the mesendoderm of the pharyngeal arches partial rescue of the most posterior ceratobranchial cartilages (3, 4, 5) was observed (Fig. 9C) . Rescue corresponded only to regions where transplanted cells contributed to the pharyngeal pouch endoderm. These results suggest that the cartilage defects in lsn/trap100 result from defect signalling from the endoderm.
Endoderm is required for the normal development of the ENS
To determine whether endoderm is necessary for the development of the ENS we injected zebrafish embryos with a specific MO directed against casanova (cas) mRNA (Dickmeis et al., 2001) . Cas is a Sox-related factor that is required for endoderm formation (Alexander et al., 1999; Dickmeis et al., 2001; Kikuchi et al., 2001 ). All Cas-MO-injected embryos exhibited cardiabifida and completely lacked intestinal endoderm as determined by foxa3 expression (Fig. 9F,H) . When compared with uninjected controls, cas morphants completely lacked phox2b expression in the ENS precursors, while expression in the hindbrain remained though the pattern of expression was altered. To confirm that this was not just a developmental delay, we stained 96 hpf Cas-MO embryos with antiHu antibodies. No Hu immunoreactivity was seen in the ventral region of the embryo where the ENS neurons normally are located (data not shown). These experiments demonstrate that endoderm is required for the development of the ENS.
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DISCUSSION
In this study, we show that lessen (lsn) is a mutation in a zebrafish trap100 gene that is orthologous to genes identified in mouse and human (Yuan et al., 1998; Zhang and Fondell, 1999) . Trap100 is required for the normal development of specific neural crest-derived structures in zebrafish. The lesion in lsn is a point mutation in trap100 that introduces a stop codon in the third exon of the gene and is predicted to severely truncate the mutant protein. We predict that the lsn mutation results in a trap100-null phenotype as the lsn Trap100 protein lacks all its predicted functional domains. Consistent with this, injection of two different morpholinos, a translation blocking morpholino or a splice-blocking morpholino, into lsn mutants does not result in a more severe phenotype, indicating that lsn is a complete loss-of-function mutant. We show that Trap100 is required for the normal proliferation of ENS precursors but not for the initial specification and migration of the ENS precursors to the anterior end of the intestine. In mice, disruption of trap100 results in an early embryonic lethal phenotype at E9-10, primarily thought to be due to placental development defects that results in anaemia and poor nutritional supply, but also due to defects in overall cell growth through out the embryo (Ito et al., 2002) . Because of this early embryonic lethality in the Trap100 -/-mouse, a crucial role for Trap100 in ENS development as well as the normal development of other vagal neural crest derived structures was previously unrecognized. trap100 has tissue specific functions during embryogenesis Previous genetic studies of murine TRAP/mediator complex components TRAP220 (Ito et al., 2000; Zhu et al., 2000) , SRB7 (Tudor et al., 1999) and Trap100 (Ito et al., 2002) have shown that the complex is essential for embryogenesis but the genetic null mutant mice have different degrees of phenotypic severity, with Srb7 -/-mice having the most severe phenotype with embryos only reaching the blastocyst stage whereasTrap220 -/-mice are viable up to E11. This variation has led to the proposal that although the TRAP/mediator complex is essential for normal cell viability, cells that express TRAP/mediator complexes with different subunit compositions may have more specific roles regulating tissue specific transcription for those cell types with that subunit composition (Ito et al., 2002) .
Our finding that the lsn mutant is viable until larval stages of zebrafish development (7 dpf) is surprising given the early Trap100-null mouse lethality (Ito et al., 2002) . Furthermore, the zebrafish Trap100-null phenotype does not exhibit similar defects in the spatiotemporal organization and proliferation in the neural tube and cardiovascular system as reported in the Trap100-null mouse (Ito et al., 2002) . By contrast, the lsn mutant phenotype clearly shows a tissue-specific role for Trap100 in both ENS/intestinal development as well as in jaw development. The jaw development phenotype is not unique for mutations that affect TRAP/mediator components. Haploinsufficiency in the TRAP/mediator subunit PAQ/ARC105 in DiGeorge syndrome indicates a potential specialized role in development of organs derived from the first and second branchial arches though the crucial role of Tbx1 also deleted in this deficiency is thought to be the critical gene that causes the branchial arch phenotype in DiGeorge (Berti et al., 2001; Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001) . The lsn mutant phenotype potentially has revealed a role for Trap100 in the development of posterior branchial arch derived cartilages. The differences between the mouse and zebrafish Trap100-null phenotypes probably have arisen due to the crucial role of Trap100 in placental development in amniotes (Ito et al., 2002) . Clarification as to whether this phenotypic difference is due to the placental defect could be revealed using mouse chimera studies. It is also possible that this difference occurs due to maternally deposited Trap100 protein rescuing any early defects in lsn mutants. trap100 function in endoderm is required for normal development of neural crest derived pharyngeal structures In this study, we show that the lsn posterior jaw cartilage mutant phenotype can be rescued by transplantation of wild-type endodermal cells. This result suggests that signals from the pharyngeal mesendoderm required for the normal development of the neural crest-derived cartilages are either reduced or missing. Pharyngeal cartilage development is a complex process requiring inductive signals from the surrounding endoderm and ectoderm (Couly et al., 2002; Crump et al., 2004a; Crump et al., 2004b; Hall, 1980) . A large number of genes are expressed in pharyngeal arches during embryogenesis, underscoring the genetic complexity of their development. A number of these genes are expressed in an evolutionarily conserved manner in zebrafish (Yelick and Schilling, 2002) and several of these genes have been shown to affect pharyngeal pouch segmentation and jaw cartilage development including fgf3 (Crump et al., 2004a; David et al., 2002) , fgf8 (Crump et al., 2004a) and tbx1 (Piotrowski et al., 2003) . The migration of the neural crest into the branchial arches is unaffected in lsn mutants, suggesting that pharyngeal pouch segmentation is normal and that expression of these genes is unaffected in lsn. Consistent with this supposition is our data showing that the development of the epibranchial placodes is normal in lsn (see Fig. S2 in the supplementary material). This is a process that has recently been shown to be endoderm dependent (Holzschuh et al., 2005; Nechiporuk et al., 2005) . Further investigation will be required to determine if other signalling molecules, such as endothelin 1, that are known to play an essential role in pharyngeal cartilage specification and differentiation are affected in lsn (Kimmel et al., 2003; Miller et al., 2000; Piotrowski et al., 2003) .
trap100 is required for proliferation of vagal neural crest derived ENS precursors
In this study, we show that the lsn ENS phenotype is due to a reduced level of proliferation of the ENS precursors. The findings that there is a reduced number of ENS precursors from the onset of migration along the gut and that fewer of these precursors are proliferating are consistent with the later reduction in the total number of enteric neurons seen at 96 hpf. Interestingly, we observe that in wild-type embryos, the majority of phosphohistone H3-positive ENS precursors are the most caudal migrating ones. This observation raises the possibility that the migration of ENS precursors along the gut is a proliferative migration, i.e. it is a combination of cells actively moving distally along the intestine combined with an increased number of new ENS precursors being generated specifically at the leading edge of the migration. This is not apparent in the mouse, where there appears to be no significant increase in proliferation in precursors at the leading edge of the wave of migration (Young et al., 2004; Young and Newgreen, 2001) . This difference may have arisen because of the very different pattern of migration of ENS precursors along the zebrafish gut when compared with mouse and avian precursors. In zebrafish ENS, precursors initially migrate along the length of the gut tube as two symmetric streams either side of the gut mesendoderm (Elworthy et al., 2005; Shepherd et al., 2004) , rather than as a rostrocaudal cork screw wave of migration within in the gut mesoderm, as seen in mouse (Kapur et al., 1992; Young et al., 2004) and avian embryos (Burns and Douarin, 1998; Epstein et al., 1991; Newgreen et al., 1996) .
An important unresolved issue is what the cellular mechanisms are that cause the ENS proliferation defect in lsn. One possibility is that Trap100 is required for transcription of genes that are directly involved in the cell cycle within the ENS precursors. Consistent with this idea, one of the other components of the TRAP/mediator complex is Cyclin C (Akoulitchev et al., 2000; Gu et al., 1999; Hengartner et al., 1998) and thus a mutation in Trap100 that perturbed the normal association of Cyclin C with the TRAP/mediator complex might potentially alter the effects of Cyclin C on the cell cycle (Ren and Rollins, 2004) . However, this proposed mechanism assumes that the mutation acts cell autonomously within the ENS precursors. As Trap100 is not expressed in ENS precursors in the intestine (Fig. 7H,I ), this cell autonomous function appears unlikely. Instead the expression of trap100 within the intestinal endoderm suggests that the ENS defect is a secondary affect of the mutation and that the lsn mutation acts cell autonomously in the intestinal endoderm. Potentially the lsn ENS phenotype could result from reduced levels of endoderm derived mitogenic factors required by the ENS precursors. Consistent with this hypothesis is our data that shows that a lack of endoderm results in a complete loss of the ENS. Further indirect support is provided by the transplantation studies that show that the lsn mutation acts cell autonomously with respect to the endoderm in the pharyngeal arches. We have not been able to test this hypothesis directly as we have been unable to generate chimaeric mutant embryos that have intestinal endoderm derived principally from wild-type cells. While transplanted blastomeres from tar*-injected donor embryos do contribute to pharyngeal pouch endoderm these transplanted cells rarely contribute to the intestinal endoderm as has been previously reported (Piotrowski et al., 2003) .
A further question that also remains unanswered relates to whether the lsn mutant phenotype results from perturbation of nuclear hormone signalling. Previous in vitro studies have shown that Trap100 is involved in enhancing transactivation of thyroid hormone receptor (TR) and vitamin D receptor (VDR) signalling in a ligand-dependent manner , and that in Trap100-deficient cells TR␣, VDR, PPAR␥ and androgen receptors have attenuated transactivation function (Ito et al., 2002) . Pharmacological block of TR signalling in zebrafish embryos between 3 dpf and 5 dpf results in a phenotype that is very similar to that seen in lsn mutant embryos with regard to the jaw, eye and intestinal epithelium phenotype (Liu and Chan, 2002) . This study also showed by RT-PCR that both TR␣ and TR␤ are expressed in a developmentally regulated fashion during this period; however, the tissue-specific expression pattern of the receptors at this embryonic stage of development has not been described. Detailed studies investigating the precise spatial and temporal expression pattern of the thyroid hormone receptors and other nuclear hormone receptors will help determine which nuclear hormone activity is potentially perturbed in the lsn mutants.
In summary, the identification of trap100 as the gene responsible for the lsn mutation has revealed a previously unappreciated tissuespecific function of this gene during development. This finding is of significant interest for studies relating to the function of TRAP/mediator complexes with different subunit compositions. Furthermore, the identification of Trap100 as having an important role in ENS development has potentially identified a new gene that may be associated with HSCR.
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